Company Overview
About Biomea Fusion
Biomea Fusion is a biotech company focused on developing novel covalent small molecules to treat serious and life-threatening diseases. With around 51 employees, the company leverages its drug design and operational expertise to create targeted therapies that aim to cure patients of their disease. Biomea Fusion has an in-house R&D engine that has produced three innovative covalent inhibitor programs currently in preclinical and clinical development.